All In Biotech

Drug Trial Radar · NCT04161755

Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery

Phase 1 Clinical Trial of Personalized Neoantigen Tumor Vaccines and Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Surgically Resected Pancreatic Cancer

Last checked: Nov 19, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

29

Actual

Start

Dec 13, 2019

Primary completion

Nov 11, 2026

Study completion Nov 11, 2026

Sponsor

Lead sponsor
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Genentech, Inc.; Massachusetts Institute of Technology
First posted
Nov 13, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety or treating pancreatic cancer with surgery to remove cancerour tissue, followed by atezolizumab, followed by a personalized cancer vaccine (PCV), and then with chemotherapy.

Conditions

  • Pancreatic Cancer

Interventions

  • AtezolizumabDrug

    Atezolizumab will be administered 6 weeks post-tumor resection (+/- 2 weeks)

  • RO7198457Biological

    RO7198457 will be administered 9 weeks post-tumor resection (+/- 2 weeks)

  • mFOLFIRINOXDrug

    mFOLFIRINOX regimen will be administered 21 weeks post-tumor resection (+/- 2 weeks)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Drug related toxicityTime frame: 2 years

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

    Basking Ridge, New Jersey

  • Memorial Sloan Kettering Monmouth (All Protocol Activities)

    Middletown, New Jersey

  • Memorial Sloan Kettering Bergen (All Protocol Activities)

    Montvale, New Jersey

  • Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities)

    Commack, New York

  • Memorial Sloan Kettering Westchester (All Protocol Activities)

    Harrison, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Memorial Sloan Kettering Nassau (All Protocol Activities)

    Rockville Centre, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.